Published online Jul 21, 2017. doi: 10.3748/wjg.v23.i27.4892
Peer-review started: February 9, 2017
First decision: April 10, 2017
Revised: April 30, 2017
Accepted: June 9, 2017
Article in press: June 12, 2017
Published online: July 21, 2017
Processing time: 173 Days and 2.8 Hours
Radiofrequency ablation (RFA) has been widely used for the treatment of various solid organ malignancies. Over the last decade, endosonographers have gradually shifted the application of RFA from porcine models to humans to treat a spectrum of diseases. RFA is performed in patients with pancreatic carcinoma who are not candidates for surgery. In this paper, we will discuss various indications for RFA, its procedural details and complications. At present, endoscopic ultrasound-guided RFA is gradually incorporated into the management of various diseases and opens a new avenue for disease treatment.
Core tip: Endoscopic ultrasound-guided radiofrequency ablation (RFA) is a rapidly emerging modality, whose application has shifted from porcine models to humans over the last decade. In this review, we provide details on the indications, thermokinetic principles and complications related to RFA, which should be judiciously applied in the management of various diseases.
